Booking Holdings Inc. (BKNG) vs Regeneron Pharmaceuticals, Inc. (REGN)
BKNG leads on 10 of 16 compared metrics, though REGN is the cheaper stock.
A side-by-side comparison of Booking Holdings Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BKNG
Booking Holdings Inc.
$164.94Consumer Cyclical
REGN
Regeneron Pharmaceuticals, Inc.
$612.14Healthcare
Total return — BKNG vs REGN
growth of $100 · last 27yBKNG +896.0%REGN +9317.5%REGN compounded faster
Log scale — wide-divergence pair
BKNG REGN
BKNG vs REGN: by the numbers
- •BKNG is the larger company ($127.81B vs $63.06B market cap).
- •REGN trades at the lower earnings multiple (14.92 vs 21.75 P/E).
- •REGN converts more revenue to profit (29.65% vs 22.23% net margin).
- •BKNG grew revenue faster over the past five years (37.43% vs 10.16% CAGR).
- •BKNG pays the higher dividend yield (0.97% vs 0.59%).
Which is better, BKNG or REGN?
Metric tally: BKNG 10 · REGN 6It depends on what you're optimizing for:
ValueREGN(lower P/E)
GrowthBKNG(faster 5Y revenue CAGR)
IncomeBKNG(higher dividend yield)
QualityBKNG(higher ROIC)
Valuation
| Metric | BKNG | REGN |
|---|---|---|
| P/E ratio | 21.75 | 14.92● |
| Forward P/E | 13.38 | 11.30● |
| P/S ratio | 4.73 | 4.42● |
| P/B ratio | — | 2.10 |
| PEG ratio | 0.14● | 3.38 |
| EV / EBITDA | 14.07 | 11.43● |
| FCF yield | 6.90%● | 6.30% |
Profitability
| Metric | BKNG | REGN |
|---|---|---|
| Gross margin | 100.00%● | 84.55% |
| Operating margin | 34.28%● | 24.32% |
| Net margin | 22.23% | 29.65%● |
| ROE | -96.88% | 14.08%● |
| ROIC | 50.82%● | 8.51% |
Dividends
| Metric | BKNG | REGN |
|---|---|---|
| Dividend yield | 0.97%● | 0.59% |
| Payout ratio | 24.14% | 8.45% |
Growth (annualized)
| Metric | BKNG | REGN |
|---|---|---|
| Revenue CAGR (5Y) | 37.43%● | 10.16% |
| EPS CAGR (5Y) | 158.62%● | 5.70% |
| FCF CAGR (5Y) | 39.83%● | 15.42% |
| Total return CAGR (5Y) | 12.81%● | 3.26% |
Frequently asked
- Which is better, BKNG or REGN?
- It depends on your goal. value: REGN (lower P/E); growth: BKNG (faster 5Y revenue CAGR); income: BKNG (higher dividend yield); quality: BKNG (higher ROIC). Across all compared metrics, BKNG leads 10 to 6.
- Is BKNG or REGN cheaper?
- On trailing earnings, REGN is cheaper: BKNG trades at a 21.75 P/E and REGN at 14.92.
- Which has grown faster, BKNG or REGN?
- Over the past five years, BKNG grew revenue faster — BKNG at a 37.43% CAGR versus REGN at 10.16%.
- Does BKNG or REGN pay a bigger dividend?
- BKNG yields 0.97% and REGN yields 0.59% based on trailing dividends and the latest price.
- Is BKNG or REGN more profitable?
- REGN runs the higher net margin — BKNG at 22.23% versus REGN at 29.65%.
- Which has been the better investment, BKNG or REGN?
- Over the past 10-year, BKNG delivered the higher annualized total return — BKNG at 12.30% versus REGN at 5.19%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Booking P/E ratioRegeneron Pharmaceuticals P/E ratioBooking dividend yieldRegeneron Pharmaceuticals dividend yieldBooking ROERegeneron Pharmaceuticals ROEBooking operating marginRegeneron Pharmaceuticals operating marginBooking revenue growthRegeneron Pharmaceuticals revenue growthBooking free cash flowRegeneron Pharmaceuticals free cash flow
Booking & Regeneron Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.